ArticleHeliyon2023
A case of extramedullary subdural spindle cell hemangioendothelioma of the thoracic spinal cord treated curatively with radiation therapy.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spindle cell hemangioendothelioma (SCH) is extremely rare. Only four cases have been reported in the spinal cord (Mahdavi et al., 1996; Abdullah et al., 2002; Nasser et al., 2016; Talan-Hranilović et al., 2007) [1-4]. In addition to surgery, radiotherapy is another effective treatment for spinal cord SCH. Two patients received radiotherapy to a total dose of 50-55Gy and benefited from it. For the treatment of this benign tumor, no one has tried to lower the radiation dose so far. Description:We report a 56-year-old man with extramedullary subdural SCH located in the T10-T11 spinal cord. Low back pain and muscle weakness are the main manifestations. Postoperative follow-up MRI examinations were performed three months after surgery showed residual tumors, he subsequently received radiotherapy and benefited from it. We gave a radiation dose of 40Gy for the first time. The neurological symptoms completely returned to normal four months after radiotherapy, and no recurrence occurred in the follow-up of 24 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.